Related Experiment Videos
Radiation-induced sarcoma of the breast
R W Mason1, G R Einspanier, R T Caleel
1Chicago College of Osteopathic Medicine of Midwestern University, Chicago, Ill, USA.
The Journal of the American Osteopathic Association
|June 1, 1996
Summary
Radiation-induced sarcomas are a rare but increasing risk after breast-conserving surgery and radiation therapy. Early detection of these sarcomas can be challenging due to post-treatment breast changes.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Breast-conserving surgery followed by radiation therapy is a common treatment for breast carcinoma.
- The incidence of radiation-induced sarcomas (RIS) following this treatment modality is increasing.
- Post-irradiation changes in the breast can complicate the diagnosis of new lesions.
Observation:
- A case of malignant fibrous histiocytoma (MFH) is presented in a 48-year-old woman.
- The sarcoma was diagnosed 5 years after lumpectomy and radiation therapy for infiltrating ductal carcinoma.
- The patient's history included breast-conserving surgery and radiation for breast cancer.
Findings:
- Malignant fibrous histiocytoma is a rare complication of radiation therapy for breast cancer.
- The latency period for radiation-induced sarcomas can be several years.
- Histologic characteristics of MFH and potential mechanisms of radiation-induced carcinogenesis are discussed.
Implications:
- Increased awareness of RIS is crucial for early diagnosis in patients with a history of breast irradiation.
- Timely diagnosis and appropriate treatment are essential for managing radiation-induced sarcomas.
- Further research into the mechanisms of radiation carcinogenesis may improve risk assessment and prevention strategies.